Data on 6,416 type 2 diabetes patients revealed those who underwent simultaneous pancreas-kidney transplantation had an 82% five-year survival rate compared with 75.5% in those who had deceased-donor kidney transplantation alone. However, researchers said the difference was related to younger donor and recipients ages in the SPK group. The study also found that the five-year death-censored graft survival was 86.2% in SPK recipients and 82.6% in those who had DDKA, a non-significant difference. The findings appear in the Clinical Journal of the American Society of Nephrology.
Published in Brief: